Skip to main content
Medicine LibreTexts


  • Page ID
  • \( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \) \( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)\(\newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\) \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\) \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\) \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\) \( \newcommand{\Span}{\mathrm{span}}\) \(\newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\) \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\) \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\) \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\) \( \newcommand{\Span}{\mathrm{span}}\)

    Aponte, J. J., Schellenberg, D., Egan, A., et al. 2009. Efficacy and safety of intermittent preven- tive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials. Lancet, 374, 1533–42.

    Bonell, C. P., Hargreaves, J., Cousens, S., et al. 2011. Alternatives to randomisation in the evaluation of public health interventions: design challenges and solutions. Journal of Epi- demiology and Community Health, 65, 582–7.

    Fine, P., Eames, K., and Heymann, D. L. 2011. ‘Herd immunity’: a rough guide. Clinical Infec- tious Diseases, 52, 911–16.

    Gysels, M., Pell, C., Mathanga, D. P., et al. 2009. Community response to intermittent prevent- ive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in five African settings. Malaria Journal, 8, 191.

    Lozano, R., Soliz, P., Gakidou, E., et al. 2006. Benchmarking of performance of Mexican states with effective coverage. Lancet, 368, 1729–41.

    Manzi, F., Hutton, G., Schellenberg, J., et al. 2008. From strategy development to routine im- plementation: the cost of Intermittent Preventive Treatment in Infants for malaria control.BMC Health Services Research, 8, 165.

    Manzi, F., Schellenberg, J., Hamis, Y., et al. 2009. Intermittent preventive treatment for malaria and anaemia control in Tanzanian infants; the development and implementation of a pub- lic health strategy. Transactions of the Royal Society of Tropical Medicine and Hygiene, 103, 79–86.

    Patel, M. M., Steele, D., Gentsch, J. R., Wecker, J., Glass, R. I., and Parashar, U. D. 2011. Real- world impact of rotavirus vaccination. Pediatric Infectious Disease Journal, 30, S1–5.

    Pool, R., Mushi, A., Schellenberg, J. A., et al. 2008. The acceptability of intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of im- munization in southern Tanzania. Malaria Journal, 7, 213.

    Ross, A., Penny, M., Maire, N., et al. 2008. Modelling the epidemiological impact of intermit- tent preventive treatment against malaria in infants. PLoS One, 3, e2661.

    Schellenberg, J. R., Abdulla, S., Nathan, R., et al. 2001. Effect of large-scale social marketing of insecticide-treated nets on child survival in rural Tanzania. Lancet, 357, 1241–7.

    Victora, C. G., Habicht, J. P., and Bryce, J. 2004. Evidence-based public health: moving beyond randomized trials. American Journal of Public Health, 94, 400–5.

    World Health Organization. 2006. The safety of medicines in public health programmes: pharmacovigilance an essential tool [Online]. Geneva: World Health Organization. Available at: < Pharmacovigilance_B.pdf>.

    References is shared under a not declared license and was authored, remixed, and/or curated by LibreTexts.

    • Was this article helpful?